Tag: HIV
-
A 44-Case Study (2020–2024): Gynecologic Cancer in HIV-Infected Patients Under ART
Introduction As antiretroviral therapy (ART) has transformed HIV from a fatal diagnosis into a manageable chronic condition, the health landscape for people living with HIV (PLWH) has changed dramatically. Among the shifts is a rising visibility of non-AIDS-defining cancers, including gynecologic malignancies. This study analyzes 44 clinical cases from 2020 through 2024 to understand how…
-
Gynecological Malignancies in HIV Patients: Insights from 44 Cases (2020–2024)
Introduction and context The advent of antiretroviral therapy (ART) has markedly extended the life expectancy of people living with HIV (PLWH). As survival improves, non-AIDS-defining cancers, including gynecological malignancies, have emerged as a significant cause of morbidity and mortality in this population. A focused study reviewing 44 cases from 2020 to 2024 provides important clues…
-
Insights from a 44-Case Study: Gynecologic Cancers in HIV Patients (2020–2024)
Background and Purpose The advent of antiretroviral therapy (ART) has dramatically increased life expectancy for people living with HIV. As patients live longer, the spectrum of health concerns has shifted, with non-AIDS-defining cancers, particularly gynecologic malignancies, emerging as a significant issue. This study examines 44 cases from 2020 to 2024 to understand patterns in incidence,…
-
US HIV Aid Cuts in Sub-Saharan Africa Risk Global Health Setbacks, Experts Warn
Overview: A shift in US HIV aid and its global implications In the wake of policy changes early in the current administration, U.S. funding for HIV programs in sub-Saharan Africa has faced reductions and restructuring. CIDRAP reports that these moves come after executive actions aimed at reconfiguring foreign-assistance programs and reshaping institutions like USAID. While…
-
US HIV Aid Cuts in Sub-Saharan Africa Pose Global Health Risks, Experts Say
Overview: Why US HIV Aid Cuts Matter The CIDRAP report highlights a looming threat to global health security as the United States scales back funding for HIV programs in sub-Saharan Africa. While foreign aid policies often shift with political winds, reductions in HIV prevention, treatment, and surveillance programs in this region can reverberate far beyond…
-
US HIV funding cuts in sub-Saharan Africa could trigger global health risk, experts warn
Overview: Why US HIV funding cuts matter beyond borders The United States’ recent shifts in foreign aid, including cuts to HIV programs in sub-Saharan Africa, are drawing fresh attention from public health experts. While policy changes may seem distant to many Americans, the potential ripple effects extend far beyond the region most directly affected. Sub-Saharan…
-
HIV funding shortfall threatens millions worldwide today
Overview: A funding crisis that affects millions A new UNAIDS report highlights a widening funding gap for HIV programs at a time when the world can least spare it. After the U.S. government paused all foreign assistance in January 2025, the ripple effects have touched clinics, pharmacies, and communities that rely on steady access to…
-
Ending AIDS Is Possible—but Only If the World Acts Now
Ending AIDS Is Possible—but Only If the World Acts Now The global fight against HIV and AIDS stands at a pivotal moment. After decades of relentless advocacy, scientific breakthroughs, and policy shifts, the path to ending AIDS is clearer than ever. Yet clarity without action yields little progress. The science is on our side, and…
-
ACTG Launches IPACE-HIV to Study Frailty Intervention
ACTG Opens IPACE-HIV to Study Frailty Intervention The AIDS Clinical Trials Group (ACTG), a leading global network focused on HIV and infectious diseases, has announced the launch of the IPACE-HIV study (Improving Physical Ability and Cellular Energy for HIV). The new trial seeks to evaluate interventions that could help mitigate frailty in people living with…
-
Vaccines Funds for Filoviruses, Pneumococcal Disease, HIV
New financing aims to accelerate vaccines for major threats Researchers and policymakers are rallying around new funding initiatives designed to fast‑track vaccines targeting filoviruses, pneumococcal disease, and HIV. The push comes amid growing recognition that diversified vaccine programs can reduce disease burden, save lives, and stabilize health systems facing unpredictable outbreaks and rising antimicrobial resistance.…